Logo image of CEVA

CEVA INC (CEVA) Stock Fundamental Analysis

NASDAQ:CEVA - Nasdaq - US1572101053 - Common Stock - Currency: USD

21.44  +0.03 (+0.14%)

After market: 21.44 0 (0%)

Fundamental Rating

5

Taking everything into account, CEVA scores 5 out of 10 in our fundamental rating. CEVA was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. No worries on liquidiy or solvency for CEVA as it has an excellent financial health rating, but there are worries on the profitability. CEVA is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CEVA had positive earnings in the past year.
CEVA had a positive operating cash flow in the past year.
CEVA had negative earnings in 4 of the past 5 years.
CEVA had a positive operating cash flow in 4 of the past 5 years.
CEVA Yearly Net Income VS EBIT VS OCF VS FCFCEVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

CEVA has a worse Return On Assets (-2.15%) than 63.64% of its industry peers.
CEVA's Return On Equity of -2.48% is on the low side compared to the rest of the industry. CEVA is outperformed by 61.82% of its industry peers.
Industry RankSector Rank
ROA -2.15%
ROE -2.48%
ROIC N/A
ROA(3y)-4.76%
ROA(5y)-2.99%
ROE(3y)-5.58%
ROE(5y)-3.51%
ROIC(3y)N/A
ROIC(5y)N/A
CEVA Yearly ROA, ROE, ROICCEVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

CEVA has a Gross Margin of 87.40%. This is amongst the best in the industry. CEVA outperforms 99.09% of its industry peers.
In the last couple of years the Gross Margin of CEVA has remained more or less at the same level.
CEVA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 87.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.67%
GM growth 5Y-0.05%
CEVA Yearly Profit, Operating, Gross MarginsCEVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

8

2. Health

2.1 Basic Checks

CEVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CEVA has been increased compared to 1 year ago.
CEVA has more shares outstanding than it did 5 years ago.
CEVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CEVA Yearly Shares OutstandingCEVA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CEVA Yearly Total Debt VS Total AssetsCEVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

CEVA has an Altman-Z score of 8.57. This indicates that CEVA is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.57, CEVA is in the better half of the industry, outperforming 74.55% of the companies in the same industry.
There is no outstanding debt for CEVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.57
ROIC/WACCN/A
WACC11.26%
CEVA Yearly LT Debt VS Equity VS FCFCEVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

CEVA has a Current Ratio of 7.45. This indicates that CEVA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 7.45, CEVA belongs to the top of the industry, outperforming 89.09% of the companies in the same industry.
A Quick Ratio of 7.45 indicates that CEVA has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 7.45, CEVA belongs to the best of the industry, outperforming 92.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.45
Quick Ratio 7.45
CEVA Yearly Current Assets VS Current LiabilitesCEVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

7

3. Growth

3.1 Past

CEVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 860.00%, which is quite impressive.
Measured over the past years, CEVA shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.60% on average per year.
The Revenue has grown by 20.23% in the past year. This is a very strong growth!
CEVA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.17% yearly.
EPS 1Y (TTM)860%
EPS 3Y-17.12%
EPS 5Y-8.6%
EPS Q2Q%220%
Revenue 1Y (TTM)20.23%
Revenue growth 3Y-4.48%
Revenue growth 5Y4.17%
Sales Q2Q%9.85%

3.2 Future

CEVA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 38.80% yearly.
Based on estimates for the next years, CEVA will show a quite strong growth in Revenue. The Revenue will grow by 9.59% on average per year.
EPS Next Y28.46%
EPS Next 2Y47.11%
EPS Next 3Y38.8%
EPS Next 5YN/A
Revenue Next Year4.1%
Revenue Next 2Y10.12%
Revenue Next 3Y9.59%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CEVA Yearly Revenue VS EstimatesCEVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M
CEVA Yearly EPS VS EstimatesCEVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 44.67, CEVA can be considered very expensive at the moment.
CEVA's Price/Earnings ratio is in line with the industry average.
CEVA is valuated expensively when we compare the Price/Earnings ratio to 26.59, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 26.78 indicates a quite expensive valuation of CEVA.
The rest of the industry has a similar Price/Forward Earnings ratio as CEVA.
When comparing the Price/Forward Earnings ratio of CEVA to the average of the S&P500 Index (22.39), we can say CEVA is valued inline with the index average.
Industry RankSector Rank
PE 44.67
Fwd PE 26.78
CEVA Price Earnings VS Forward Price EarningsCEVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as CEVA.
Industry RankSector Rank
P/FCF 486.11
EV/EBITDA N/A
CEVA Per share dataCEVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

CEVA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as CEVA's earnings are expected to grow with 38.80% in the coming years.
PEG (NY)1.57
PEG (5Y)N/A
EPS Next 2Y47.11%
EPS Next 3Y38.8%

0

5. Dividend

5.1 Amount

No dividends for CEVA!.
Industry RankSector Rank
Dividend Yield N/A

CEVA INC

NASDAQ:CEVA (6/10/2025, 8:00:00 PM)

After market: 21.44 0 (0%)

21.44

+0.03 (+0.14%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners89.78%
Inst Owner Change3.98%
Ins Owners2.67%
Ins Owner Change26.46%
Market Cap512.84M
Analysts81.67
Price Target34.68 (61.75%)
Short Float %5.65%
Short Ratio4.5
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.06%
Min EPS beat(2)-15.97%
Max EPS beat(2)-0.15%
EPS beat(4)2
Avg EPS beat(4)159.87%
Min EPS beat(4)-15.97%
Max EPS beat(4)614.39%
EPS beat(8)3
Avg EPS beat(8)31.07%
EPS beat(12)5
Avg EPS beat(12)15.42%
EPS beat(16)9
Avg EPS beat(16)19%
Revenue beat(2)1
Avg Revenue beat(2)-2.93%
Min Revenue beat(2)-9.83%
Max Revenue beat(2)3.96%
Revenue beat(4)2
Avg Revenue beat(4)1.84%
Min Revenue beat(4)-9.83%
Max Revenue beat(4)13.87%
Revenue beat(8)2
Avg Revenue beat(8)-4.06%
Revenue beat(12)3
Avg Revenue beat(12)-7.15%
Revenue beat(16)7
Avg Revenue beat(16)-3.79%
PT rev (1m)-8.52%
PT rev (3m)-8.52%
EPS NQ rev (1m)-48%
EPS NQ rev (3m)-48%
EPS NY rev (1m)-11.41%
EPS NY rev (3m)-11.41%
Revenue NQ rev (1m)-7.92%
Revenue NQ rev (3m)-7.92%
Revenue NY rev (1m)-1.3%
Revenue NY rev (3m)-5.38%
Valuation
Industry RankSector Rank
PE 44.67
Fwd PE 26.78
P/S 4.7
P/FCF 486.11
P/OCF 150.09
P/B 1.91
P/tB 2.45
EV/EBITDA N/A
EPS(TTM)0.48
EY2.24%
EPS(NY)0.8
Fwd EY3.73%
FCF(TTM)0.04
FCFY0.21%
OCF(TTM)0.14
OCFY0.67%
SpS4.56
BVpS11.25
TBVpS8.74
PEG (NY)1.57
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.15%
ROE -2.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 87.4%
FCFM 0.97%
ROA(3y)-4.76%
ROA(5y)-2.99%
ROE(3y)-5.58%
ROE(5y)-3.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.67%
GM growth 5Y-0.05%
F-Score6
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 58.8%
Cap/Sales 2.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.45
Quick Ratio 7.45
Altman-Z 8.57
F-Score6
WACC11.26%
ROIC/WACCN/A
Cap/Depr(3y)65%
Cap/Depr(5y)55.38%
Cap/Sales(3y)3.01%
Cap/Sales(5y)2.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)860%
EPS 3Y-17.12%
EPS 5Y-8.6%
EPS Q2Q%220%
EPS Next Y28.46%
EPS Next 2Y47.11%
EPS Next 3Y38.8%
EPS Next 5YN/A
Revenue 1Y (TTM)20.23%
Revenue growth 3Y-4.48%
Revenue growth 5Y4.17%
Sales Q2Q%9.85%
Revenue Next Year4.1%
Revenue Next 2Y10.12%
Revenue Next 3Y9.59%
Revenue Next 5YN/A
EBIT growth 1Y48.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year252.3%
EBIT Next 3Y100.68%
EBIT Next 5YN/A
FCF growth 1Y109.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y142.82%
OCF growth 3Y-48.76%
OCF growth 5Y-18.53%